These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 27358406

  • 1. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M, Jiang M, Chen Y, Zhang S, Zhang W, Yang X, Li X, Li Y, Duan S, Han J, Duan Y.
    J Biol Chem; 2016 Aug 12; 291(33):16977-89. PubMed ID: 27358406
    [Abstract] [Full Text] [Related]

  • 2. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, Murata Y, Kim-Mitsuyama S, Kawada T, Itabe H, Takeya M, Nishikawa T, Tsuruzoe K, Araki E.
    J Biol Chem; 2008 Apr 11; 283(15):9852-62. PubMed ID: 18208815
    [Abstract] [Full Text] [Related]

  • 3. Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE.
    Yang X, Zhang W, Chen Y, Li Y, Sun L, Liu Y, Liu M, Yu M, Li X, Han J, Duan Y.
    J Biol Chem; 2016 Jul 15; 291(29):15108-18. PubMed ID: 27226602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma.
    Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM, Nicholson AC.
    J Biol Chem; 2000 Jan 14; 275(2):1241-6. PubMed ID: 10625669
    [Abstract] [Full Text] [Related]

  • 7. Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma.
    Munteanu A, Taddei M, Tamburini I, Bergamini E, Azzi A, Zingg JM.
    J Biol Chem; 2006 Mar 10; 281(10):6489-97. PubMed ID: 16407258
    [Abstract] [Full Text] [Related]

  • 8. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT, Cao Y, Wang TQ, Wang LJ, Guo J, Zhou XS, Xu SW, Liu WH, Liu PQ, Huang HQ.
    Eur J Pharmacol; 2011 Jan 10; 650(1):275-84. PubMed ID: 20854809
    [Abstract] [Full Text] [Related]

  • 9. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, Ong H.
    Cardiovasc Res; 2009 Aug 01; 83(3):457-64. PubMed ID: 19377069
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin inhibited oxLDL-induced proatherogenic effects through calpain-1-PPARγ-CD36 pathway.
    Yang X, Yin M, Yu L, Lu M, Wang H, Tang F, Zhang Y.
    Can J Physiol Pharmacol; 2016 Dec 01; 94(12):1336-1343. PubMed ID: 27733051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
    Namgaladze D, Kemmerer M, von Knethen A, Brüne B.
    Cardiovasc Res; 2013 Jun 01; 98(3):479-87. PubMed ID: 23531513
    [Abstract] [Full Text] [Related]

  • 13. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma.
    Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM, Hajjar DP, Nicholson AC.
    J Lipid Res; 2000 May 01; 41(5):688-96. PubMed ID: 10787429
    [Abstract] [Full Text] [Related]

  • 14. Anthocyanin extracted from Hibiscus attenuate oxidized LDL-mediated foam cell formation involving regulation of CD36 gene.
    Kao ES, Tseng TH, Lee HJ, Chan KC, Wang CJ.
    Chem Biol Interact; 2009 May 15; 179(2-3):212-8. PubMed ID: 19330881
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways.
    Jiang M, Zhang L, Ma X, Hu W, Chen Y, Yu M, Wang Q, Li X, Yin Z, Zhu Y, Gao X, Hajjar DP, Duan Y, Han J.
    Biochem J; 2013 Sep 15; 454(3):467-77. PubMed ID: 23805908
    [Abstract] [Full Text] [Related]

  • 17. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois MG, Febbraio M, Silverstein RL, Tremblay A, Ong H.
    FASEB J; 2005 Nov 15; 19(13):1869-71. PubMed ID: 16123174
    [Abstract] [Full Text] [Related]

  • 18. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation.
    Min KJ, Um HJ, Cho KH, Kwon TK.
    Food Chem Toxicol; 2013 Aug 15; 58():77-85. PubMed ID: 23603106
    [Abstract] [Full Text] [Related]

  • 19. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J, Hajjar DP, Febbraio M, Nicholson AC.
    J Biol Chem; 1997 Aug 22; 272(34):21654-9. PubMed ID: 9261189
    [Abstract] [Full Text] [Related]

  • 20. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages.
    Rios FJ, Gidlund M, Jancar S.
    Cell Physiol Biochem; 2011 Aug 22; 27(3-4):363-72. PubMed ID: 21471725
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.